IL6R and COVID-19: Protein-protein docking between COVID-19-Spike and IL6 receptor (IL6R)/IL6/IL6 receptor subunit beta (IL6ST) was simulated to verify whether IL6, the core target identified through our network pharmacology-based approach, was a pathogenic target.